Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

4 recruiting

Enrollment Performance

Analytics

N/A
6(100.0%)
6Total
N/A(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT06905223Not ApplicableRecruiting

A Pilot Study of Synbiotics in Adults With Depressive Symptoms

Role: lead

NCT06647043Not ApplicableRecruiting

Evaluate the Effect of Synbiotics in Irritable Bowel Syndrome

Role: collaborator

NCT06537882Not ApplicableActive Not Recruiting

Evaluate the Effect of Synbiotics on MAFLD

Role: lead

NCT06636513Not ApplicableRecruiting

A Single-arm, Open-label Clinical Trial to Evaluate the Effect of SMT04 in Irritable Bowel Syndrome (IBS)

Role: collaborator

NCT06560385Not ApplicableRecruiting

Alleviation of Alopecia in Breast Cancer Patient Using Synbiotics Formula

Role: lead

NCT05885373Not ApplicableCompleted

A Clinical Study to Evaluate the Effect of SIM01 in Female With NAFLD

Role: lead

All 6 trials loaded